Newrology
A fresh approach to helping patients thrive
A pipeline for patient-kind
Harmony Biosciences’ patient-focused drug development model uses patient insights to inform clinical research programs.
The Struggle to Stay Awake: Recognizing Pediatric Narcolepsy
In this television broadcast about pediatric narcolepsy from The Lifetime Network, sponsored by Harmony Biosciences, learn about this often underdiagnosed and misdiagnosed disorder and meet a mother who trusted her instincts to help her son.
Feb 24, 2026
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
Feb 17, 2026
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
Feb 10, 2026
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
available now
Discover our Products
From discovery to delivery, Harmony Biosciences is committed to getting medicines to the people who need them most.
The Harmony Team
Meet our leaders who share an uncommon commitment for addressing patients’ unmet medical needs.
Senior Leadership